AU2020370590B2 - Polynucleotide-linked bioconjugates and methods of making and using - Google Patents

Polynucleotide-linked bioconjugates and methods of making and using Download PDF

Info

Publication number
AU2020370590B2
AU2020370590B2 AU2020370590A AU2020370590A AU2020370590B2 AU 2020370590 B2 AU2020370590 B2 AU 2020370590B2 AU 2020370590 A AU2020370590 A AU 2020370590A AU 2020370590 A AU2020370590 A AU 2020370590A AU 2020370590 B2 AU2020370590 B2 AU 2020370590B2
Authority
AU
Australia
Prior art keywords
nucleic acid
acid linker
polynucleotide
modified
substrate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2020370590A
Other languages
English (en)
Other versions
AU2020370590A1 (en
Inventor
Christopher Dwyer
Craig LABODA
Michael STADNISKY
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Phitonex Inc
Original Assignee
Phitonex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phitonex Inc filed Critical Phitonex Inc
Publication of AU2020370590A1 publication Critical patent/AU2020370590A1/en
Application granted granted Critical
Publication of AU2020370590B2 publication Critical patent/AU2020370590B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6889—Conjugates wherein the antibody being the modifying agent and wherein the linker, binder or spacer confers particular properties to the conjugates, e.g. peptidic enzyme-labile linkers or acid-labile linkers, providing for an acid-labile immuno conjugate wherein the drug may be released from its antibody conjugated part in an acidic, e.g. tumoural or environment
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/544—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic
    • G01N33/548—Carbohydrates, e.g. dextran
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/549—Sugars, nucleosides, nucleotides or nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0054—Macromolecular compounds, i.e. oligomers, polymers, dendrimers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/533—Production of labelled immunochemicals with fluorescent label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/585—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2563/00—Nucleic acid detection characterized by the use of physical, structural and functional properties
    • C12Q2563/107—Nucleic acid detection characterized by the use of physical, structural and functional properties fluorescence
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2563/00—Nucleic acid detection characterized by the use of physical, structural and functional properties
    • C12Q2563/131—Nucleic acid detection characterized by the use of physical, structural and functional properties the label being a member of a cognate binding pair, i.e. extends to antibodies, haptens, avidin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2563/00—Nucleic acid detection characterized by the use of physical, structural and functional properties
    • C12Q2563/149—Particles, e.g. beads
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2563/00—Nucleic acid detection characterized by the use of physical, structural and functional properties
    • C12Q2563/179—Nucleic acid detection characterized by the use of physical, structural and functional properties the label being a nucleic acid
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2458/00—Labels used in chemical analysis of biological material
    • G01N2458/10—Oligonucleotides as tagging agents for labelling antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU2020370590A 2019-10-25 2020-10-24 Polynucleotide-linked bioconjugates and methods of making and using Active AU2020370590B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962926037P 2019-10-25 2019-10-25
US62/926,037 2019-10-25
PCT/US2020/057247 WO2021081466A1 (en) 2019-10-25 2020-10-24 Polynucleotide-linked bioconjugates and methods of making and using

Publications (2)

Publication Number Publication Date
AU2020370590A1 AU2020370590A1 (en) 2022-04-14
AU2020370590B2 true AU2020370590B2 (en) 2025-01-02

Family

ID=75620294

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2020370590A Active AU2020370590B2 (en) 2019-10-25 2020-10-24 Polynucleotide-linked bioconjugates and methods of making and using

Country Status (7)

Country Link
US (3) US12558433B2 (enExample)
EP (1) EP4048313A4 (enExample)
JP (1) JP2022553737A (enExample)
KR (1) KR102813615B1 (enExample)
CN (1) CN114555125A (enExample)
AU (1) AU2020370590B2 (enExample)
WO (1) WO2021081466A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022212643A2 (en) * 2021-04-01 2022-10-06 Qcdx Llc Systems and compositions for detecting a biological sample and methods thereof
US20250105470A1 (en) 2021-12-01 2025-03-27 Lg Energy Solution, Ltd. Cylindrical battery, current collector applied thereto, and battery pack and vehicle including the cylindrical battery

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007008550A1 (en) * 2005-07-07 2007-01-18 Beckman Coulter, Inc. Labeled complimentary oligonucleotides to detect oligonucleotide-linked ligands
WO2013177046A1 (en) * 2012-05-21 2013-11-28 Solulink, Inc. Methods and/or use of oligonucleotide conjugates for suppressing background due to cross-hybridization
WO2018022809A1 (en) * 2016-07-27 2018-02-01 The Board Of Trustees Of The Leland Stanford Junior University Highly-multiplexed fluorescent imaging

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4318721B2 (ja) * 2004-10-15 2009-08-26 独立行政法人科学技術振興機構 ｍＲＮＡ−ピューロマイシン−タンパク質連結体作製用リンカー
JP2007275006A (ja) 2006-04-10 2007-10-25 Hitachi High-Technologies Corp 核酸検出用プローブ作製法
US8309306B2 (en) 2008-11-12 2012-11-13 Nodality, Inc. Detection composition
WO2010059858A1 (en) * 2008-11-19 2010-05-27 Duke University Manassantin compounds and methods of making and using same
WO2010099230A2 (en) 2009-02-25 2010-09-02 Illumina, Inc. Separation of pyrophosphate release and pyrophosphate detection
US8889350B2 (en) 2010-03-26 2014-11-18 Swift Biosciences, Inc. Methods and compositions for isolating polynucleotides
JP5759678B2 (ja) * 2010-04-14 2015-08-05 国立大学法人埼玉大学 核酸リンカー
WO2011158174A1 (en) 2010-06-17 2011-12-22 Koninklijke Philips Electronics N.V. Multi epitope assay
US8946389B2 (en) * 2011-04-25 2015-02-03 University Of Washington Compositions and methods for multiplex biomarker profiling
WO2013188756A1 (en) * 2012-06-15 2013-12-19 The University Of Chicago Oligonucleotide-mediated quantitative multiplexed immunoassays
EP3865576A1 (en) * 2014-12-15 2021-08-18 Dicerna Pharmaceuticals, Inc. Ligand-modified double-stranded nucleic acids
KR20180085717A (ko) * 2015-09-24 2018-07-27 에이비비트로, 엘엘씨 친화성-올리고뉴클레오타이드 콘쥬게이트 및 그것의 사용
KR102795781B1 (ko) * 2017-06-16 2025-04-15 듀크 유니버시티 개선된 라벨 검출, 계산, 분석물 감지, 및 조정 가능한 난수 생성을 위한 공진기 네트워크
US11549939B2 (en) 2017-06-21 2023-01-10 Dynamic Biosensors Gmbh Method for detecting and/or characterizing the interaction between proteins and small molecules

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007008550A1 (en) * 2005-07-07 2007-01-18 Beckman Coulter, Inc. Labeled complimentary oligonucleotides to detect oligonucleotide-linked ligands
WO2013177046A1 (en) * 2012-05-21 2013-11-28 Solulink, Inc. Methods and/or use of oligonucleotide conjugates for suppressing background due to cross-hybridization
WO2018022809A1 (en) * 2016-07-27 2018-02-01 The Board Of Trustees Of The Leland Stanford Junior University Highly-multiplexed fluorescent imaging

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
AMY C FLOR ET AL: "DNA-Directed Assembly of Antibody-Fluorophore Conjugates for Quantitative Multiparametric Flow Cytometry", CHEMBIOCHEM, Jvol. 15, no. 2, 27 December 2013 (2013-12-27), pages 267 - 275 *
PARK JUN YOUNG ET AL: "Hybridization-based aptamer labeling using complementary oligonucleotide platform for PET and optical imaging", BIOMATERIALS, ELSEVIER, AMSTERDAM, NL, vol. 100, 24 May 2016 (2016-05-24), pages 143 - 151 *

Also Published As

Publication number Publication date
JP2022553737A (ja) 2022-12-26
KR102813615B1 (ko) 2025-05-29
EP4048313A4 (en) 2023-05-31
US12558433B2 (en) 2026-02-24
US20240156981A1 (en) 2024-05-16
WO2021081466A1 (en) 2021-04-29
KR20220088437A (ko) 2022-06-27
CN114555125A (zh) 2022-05-27
US20220168441A1 (en) 2022-06-02
AU2020370590A1 (en) 2022-04-14
EP4048313A1 (en) 2022-08-31
US20220218841A1 (en) 2022-07-14

Similar Documents

Publication Publication Date Title
JP5860922B2 (ja) ビーズまたは他の捕捉物を用いた分子または粒子の超高感度検出
JP4511363B2 (ja) 相互作用する分子を検出するためのｆｒｅｔプローブおよび方法
Dos Santos et al. Recent developments in lanthanide-to-quantum dot FRET using time-gated fluorescence detection and photon upconversion
US20240156981A1 (en) Polynucleotide-linked bioconjugates and methods of making and using
US20150004598A1 (en) Compositions and methods for multiplex biomarker profiling
JP2009540326A (ja) 結合及び非結合ラベルの測定による検体検出の増加した特異性
US7741128B2 (en) Cooperative reporter systems, components, and methods for analyte detection
KR20200024736A (ko) 타겟 물질 검출을 위한 방법 및 키트
US20250092441A1 (en) Sequential staining for multiplex analyses of tissues and cells
EP1900822B1 (en) Method for simultaneous analysis of multiple biological reactions or changes in in vivo conditions
US20240175072A1 (en) Method And Composition For Multiplexed And Multimodal Single Cell Analysis
Zhao et al. Amplification-free dye-labeled digital immunoassay: From subpicomolar to attomolar
JP2018537071A (ja) 固定化された核酸を使用して分子相互作用を検出するための方法
WO2023008271A1 (ja) 核酸計測デバイス、その設計方法、製造方法及び計測方法
US20240002911A1 (en) Methods Of Signal Amplification
CN116457471A (zh) 信号放大方法
CN116829728A (zh) 用于多重和多模式单细胞分析的方法和组合物
Kim et al. Multiplexed Detection Using Quantum Dots

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)